Page last updated on October 8, 2025
Advanced Biomed Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-10-08 17:00:48 EDT.
Filings
10-K filed on 2025-10-08
Advanced Biomed Inc. filed a 10-K at 2025-10-08 17:00:48 EDT
Accession Number: 0001213900-25-097465
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
ITEM 1C. Cybersecurity We recognize the importance of identifying, assessing, and managing material risks from cybersecurity threats, as defined in Item 106(a) of Regulation S-K. Our risk management program is designed to detect, evaluate, and mitigate cybersecurity risks, and is informed by applicable laws, regulations, and industry best practices. Our Chief Executive Officer oversees our cybersecurity program and leads our incident response efforts. The incident response team is cross-functional, drawing members from cybersecurity, IT support, mining operations, software engineering, compliance, legal, contractors, and partners. When a potential incident is detected, the cybersecurity team validates it before escalating to the incident response team for triage. Significant incidents are escalated to executive management. Response actions such as allocating resources, setting priorities, creating action plans, and notifying external parties are directed by the Chief Executive Officer in coordination with the cross-functional working group. We also consult outside counsel on materiality assessments and disclosure decisions, with executive management making the final determinations. In 2025, we did not identify any cybersecurity threats that materially affected, or are reasonably likely to materially affect , our strategy, operations, or financial condition. However, no program can eliminate all risks, and we cannot guarantee that undetected incidents have not occurred. See Part I, Item 1A. “Risk Factors” of this Annual Report for further details. 83
Company Information
Name | Advanced Biomed Inc. |
CIK | 0001941029 |
SIC Description | Services-Medical Laboratories |
Ticker | ADVB - Nasdaq |
Website | |
Category | Emerging growth company |
Fiscal Year End |